AMENDMENT NO. 1 TO ARRANGEMENT AGREEMENTArrangement Agreement • November 19th, 2007 • Lorus Therapeutics Inc • Biological products, (no disgnostic substances) • Ontario
Contract Type FiledNovember 19th, 2007 Company Industry JurisdictionThis AMENDMENT NO. 1 TO ARRANGEMENT AGREEMENT is made as of May 14, 2007 (“Amending Agreement”) by and between Lorus Therapeutics Inc. (“Old Lorus”), NuChem Pharmaceuticals Inc. (“NuChem”), GeneSense Technologies Inc. (“GeneSense”), 6650309 Canada Inc. (“New Lorus”), Pinnacle International Lands, Inc. (“Pinnacle”), and 6707157 Canada Inc. (“Investor”).